DigestRedComo funciona
Red
/
Empresas
St
No verificado

Strand Therapeutics

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMedicina - VariosSalud

10 Comunicados de prensa

Ver todos los comunicados de prensa
29/04/2026
Strand Therapeutics Appoints Kunal Bhatia as Chief Financial Officer
Fuente
Strand Therapeutics
Editor
Business Wire
1.00
0
27/04/2026
Eventos
Web y redes sociales
Salud
Biotecnología
Medicina - Varios
Sanidad
Farmacéutica
Strand Therapeutics to Present Preclinical Data on Its Programmable mRNA In Vivo CAR-T Platform at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Fuente
Strand Therapeutics
Editor
Business Wire
1.00
0
15/12/2025
Eventos
Industria
Oncología
Salud
Biotecnología
Medicina - Varios
Farmacéutica
Strand Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Fuente
Strand Therapeutics
Editor
Business Wire
1.00
0
02/12/2025
Strand Therapeutics Appoints Jeb Keiper to Board of Directors
Fuente
Strand Therapeutics
Editor
Business Wire
1.00
0
05/11/2025
Strand Therapeutics Promotes Prashant Nambiar to Chief Scientific Officer and Appoints Ethan Cash as Senior Vice President, Head of Portfolio Management and Program Development
Fuente
Strand Therapeutics
Editor
Business Wire
1.00
0
21/08/2025
Strand Therapeutics Appoints Dr. Jason J. Luke as Chief Medical Officer
Fuente
Strand Therapeutics
Editor
Business Wire
1.00
0
21/08/2025
Strand Therapeutics Appoints Dr. Jason J. Luke as Chief Medical Officer
Fuente
Strand Therapeutics
Editor
Business Wire
1.00
0
07/08/2025
Oncología
Salud
Biotecnología
Medicina - Varios
Ciencia
Strand Therapeutics Raises $153 Million Series B Financing to Further Advance Programmable mRNA Therapeutic Pipeline
Fuente
Strand Therapeutics
Editor
Business Wire
1.00
0
28/05/2025
Ciencia
Biotecnología
Farmacéutica
Oncología
Salud
Medicina - Varios
Industria
Strand Therapeutics Announces Initial First-in-human Phase 1 Data for STX-001 in Patients with Advanced Solid Tumors at The 2025 ASCO Annual Meeting
Fuente
Strand Therapeutics
Editor
Business Wire
1.00
0
28/04/2025
Eventos
Industria
Salud
Biotecnología
Sanidad
Ciencia
Potential First-in-Class Data from Preclinical Program for STX-003, a Programmable mRNA Therapy to Treat Solid Tumor Cancers
Fuente
Strand Therapeutics
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0